Annual Cash & Cash Equivalents
$99.68 M
-$24.25 M-19.57%
December 31, 2023
Summary
- As of February 7, 2025, WGS annual cash & cash equivalents is $99.68 million, with the most recent change of -$24.25 million (-19.57%) on December 31, 2023.
- During the last 3 years, WGS annual cash & cash equivalents has fallen by -$8.45 million (-7.82%).
- WGS annual cash & cash equivalents is now -75.12% below its all-time high of $400.57 million, reached on December 31, 2021.
Performance
WGS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$57.89 M
+$1.82 M+3.24%
September 30, 2024
Summary
- As of February 7, 2025, WGS quarterly cash and cash equivalents is $57.89 million, with the most recent change of +$1.82 million (+3.24%) on September 30, 2024.
- Over the past year, WGS quarterly cash and cash equivalents has increased by +$1.82 million (+3.24%).
- WGS quarterly cash and cash equivalents is now -87.45% below its all-time high of $461.28 million, reached on September 1, 2021.
Performance
WGS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WGS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.6% | +3.2% |
| 3 y3 years | -7.8% | -71.3% |
| 5 y5 years | - | -71.3% |
WGS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.1% | at low | -85.5% | +3.2% |
| 5 y | 5-year | -75.1% | at low | -87.5% | +3.2% |
| alltime | all time | -75.1% | at low | -87.5% | +3.2% |
GeneDx Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $57.89 M(+3.2%) |
| Jun 2024 | - | $56.08 M(-33.0%) |
| Mar 2024 | - | $83.67 M(-16.1%) |
| Dec 2023 | $99.68 M(-19.6%) | $99.68 M(+14.1%) |
| Sep 2023 | - | $87.39 M(-44.2%) |
| Jun 2023 | - | $156.66 M(-22.4%) |
| Mar 2023 | - | $201.90 M(+62.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $123.93 M(-69.1%) | $123.93 M(-35.2%) |
| Sep 2022 | - | $191.36 M(-32.8%) |
| Jun 2022 | - | $284.65 M(-9.6%) |
| Mar 2022 | - | $315.00 M(-21.4%) |
| Dec 2021 | $400.57 M(+270.4%) | - |
| Dec 2021 | - | $400.57 M(-13.2%) |
| Sep 2021 | - | $461.28 M(+326.6%) |
| Dec 2020 | $108.13 M | $108.13 M |
FAQ
- What is GeneDx Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GeneDx Holdings?
- What is GeneDx Holdings annual cash & cash equivalents year-on-year change?
- What is GeneDx Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GeneDx Holdings?
- What is GeneDx Holdings quarterly cash and cash equivalents year-on-year change?
What is GeneDx Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of WGS is $99.68 M
What is the all time high annual cash & cash equivalents for GeneDx Holdings?
GeneDx Holdings all-time high annual cash & cash equivalents is $400.57 M
What is GeneDx Holdings annual cash & cash equivalents year-on-year change?
Over the past year, WGS annual cash & cash equivalents has changed by -$24.25 M (-19.57%)
What is GeneDx Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of WGS is $57.89 M
What is the all time high quarterly cash and cash equivalents for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash and cash equivalents is $461.28 M
What is GeneDx Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, WGS quarterly cash and cash equivalents has changed by +$1.82 M (+3.24%)